1. Biological Earth observation with animal sensors. (April 2022) Authors: Jetz, Walter; Tertitski, Grigori; Kays, Roland; Mueller, Uschi; Wikelski, Martin; Åkesson, Susanne; Anisimov, Yury; Antonov, Aleksey; Arnold, Walter; Bairlein, Franz; Baltà, Oriol; Baum, Diane; Beck, Mario; Belonovich, Olga; Belyaev, Mikhail; Berger, Matthias; Berthold, Peter; Bittner, Steffen; B... Journal: Trends in ecology & evolution Issue: Volume 37:Number 4(2022) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biological Earth observation with animal sensors. (April 2022) Authors: Jetz, Walter; Tertitski, Grigori; Kays, Roland; Mueller, Uschi; Wikelski, Martin; Åkesson, Susanne; Anisimov, Yury; Antonov, Aleksey; Arnold, Walter; Bairlein, Franz; Baltà, Oriol; Baum, Diane; Beck, Mario; Belonovich, Olga; Belyaev, Mikhail; Berger, Matthias; Berthold, Peter; Bittner, Steffen; B... Journal: Trends in ecology & evolution Issue: Volume 37:Number 4(2022) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus–positive Patients Treated With Protease Inhibitor Monotherapy. (31st July 2018) Authors: Haddow, Lewis J; Godi, Claudia; Sokolska, Magdalena; Cardoso, M Jorge; Oliver, Ruth; Winston, Alan; Stöhr, Wolfgang; Clarke, Amanda; Chen, Fabian; Williams, Ian G; Johnson, Margaret; Paton, Nick; Arenas-Pinto, Alejandro; Golay, Xavier; Jäger, Hans Rolf Journal: Clinical infectious diseases Issue: Volume 68:Number 6(2019) Page Start: 1031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. Issue 4 (23rd December 2017) Authors: Glatt, Sophie; Baeten, Dominique; Baker, Terry; Griffiths, Meryn; Ionescu, Lucian; Lawson, Alastair D G; Maroof, Ash; Oliver, Ruth; Popa, Serghei; Strimenopoulou, Foteini; Vajjah, Pavan; Watling, Mark I L; Yeremenko, Nataliya; Miossec, Pierre; Shaw, Stevan Journal: Annals of the rheumatic diseases Issue: Volume 77:Issue 4(2018) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Flexible Large‐Area Light‐Emitting Devices Based on WS2 Monolayers. Issue 20 (26th July 2020) Authors: Andrzejewski, Dominik; Oliver, Ruth; Beckmann, Yannick; Grundmann, Annika; Heuken, Michael; Kalisch, Holger; Vescan, Andrei; Kümmell, Tilmar; Bacher, Gerd Journal: Advanced optical materials Issue: Volume 8:Issue 20(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetic‐pharmacodynamic modelling of the anti‐FcRn monoclonal antibody rozanolixizumab: Translation from preclinical stages to the clinic. (23rd November 2021) Authors: Lledo‐Garcia, Rocio; Dixon, Kate; Shock, Anthony; Oliver, Ruth Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 1(2022) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease. (13th April 2015) Authors: Wade, Janet R.; Parker, Gerry; Kosutic, Gordana; Feagen, Brian G.; Sandborn, William J.; Laveille, Christian; Oliver, Ruth Journal: Journal of clinical pharmacology Issue: Volume 55:Number 8(2015:Aug.) Page Start: 866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease. (13th April 2015) Authors: Wade, Janet R.; Parker, Gerry; Kosutic, Gordana; Feagen, Brian G.; Sandborn, William J.; Laveille, Christian; Oliver, Ruth Journal: Journal of clinical pharmacology Issue: Volume 55:Number 8(2015:Aug.) Page Start: 866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Population Pharmacokinetics and Exposure‐Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus. (9th January 2023) Authors: Acharya, Chayan; Magnusson, Mats O.; Vajjah, Pavan; Oliver, Ruth; Zamacona, Miren Journal: Journal of clinical pharmacology Issue: Volume 63:Number 4(2023) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and pharmacokinetics of olokizumab, an anti‐IL‐6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study. Issue 5 (26th May 2014) Authors: Kretsos, Kosmas; Golor, Georg; Jullion, Astrid; Hickling, Matthew; McCabe, Suzanne; Shaw, Stevan; Jose, Joby; Oliver, Ruth Journal: Clinical pharmacology in drug development Issue: Volume 3:Issue 5(2014:Sep./Oct.) Page Start: 388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗